Federated Hermes’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.29M Sell
293,842
-146,042
-33% -$4.61M 0.02% 588
2025
Q1
$14.6M Sell
439,884
-52,919
-11% -$1.76M 0.03% 471
2024
Q4
$17M Sell
492,803
-49,276
-9% -$1.7M 0.04% 444
2024
Q3
$21.7M Buy
542,079
+16,555
+3% +$662K 0.05% 405
2024
Q2
$15.9M Sell
525,524
-17
-0% -$513 0.04% 447
2024
Q1
$17.6M Buy
525,541
+204
+0% +$6.85K 0.04% 441
2023
Q4
$17M Buy
525,337
+501,809
+2,133% +$16.2M 0.04% 426
2023
Q3
$771K Buy
23,528
+355
+2% +$11.6K ﹤0.01% 1208
2023
Q2
$815K Sell
23,173
-15,363
-40% -$541K ﹤0.01% 1204
2023
Q1
$1.26M Buy
38,536
+9,013
+31% +$294K ﹤0.01% 1097
2022
Q4
$1.63M Buy
29,523
+2,242
+8% +$124K ﹤0.01% 977
2022
Q3
$1.21M Sell
27,281
-12,120
-31% -$537K ﹤0.01% 1061
2022
Q2
$1.92M Buy
39,401
+11,146
+39% +$543K 0.01% 941
2022
Q1
$1.38M Buy
+28,255
New +$1.38M ﹤0.01% 1137